miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.

CONCLUSIONS: The results of the current study demonstrate that oncogene miR-566 is a potential biomarker not only for diagnosis but also for prognosis for RCC.
PMID: 29604591 [PubMed - as supplied by publisher]

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - March 28, 2018 Category: Drugs & Pharmacology Authors: Pan X, Quan J, Li Z, Zhao L, Zhou L, Jinling X, Weijie X, Guan X, Li H, Yang S, Gui Y, Lai Y Tags: Biomed Pharmacother Source Type: research